-
[Illinois] Light/Matter Interactions in Biology
13 Apr 2017 | | Contributor(s):: Prashant K Jain
Light/Matter Interactions at the Nano-Bio Interface Workshop
-
[Illinois] Photonic Integrated Circuit Chips and Modules
13 Apr 2017 | | Contributor(s):: Frederick A. Kish
9/8/2016 MNTL Industry Affiliates Program
-
[Illinois] Plasmonics and Its Applications Workshop 2016
25 Apr 2016 | | Contributor(s):: George C. Schatz, Bjorn Reinhard, Jennifer Hollingsworth, Kathy Willets, Jeremy Smith, AbderRahman N Sobh, Jao van de Lagemaat, Amanda Haes, Maiken Mikkelsen, Prashant Nagpal, sayantani ghosh, Emad Tajkhorshid, Nicholas Kotov, Anatoily Pinchuk
The study of plasmonics has been around for several decades now. The study of the interaction between the electromagnetic field and the free electrons in metal have been found as advantageous for applications in devices and more recently, in biological systems. The focus of this workshop...
-
[Illinois] Signal Processing at Light Speed: Ultrashort Optical Pulse Generation with Arbitrary Waveforms
29 Jan 2016 | | Contributor(s):: Claire Mcghee
We aim to further improve early detection of cancer biomarkers, including metal ion and small molecules, using functional DNA as the selective component for photonic crystal surface enhanced Raman scattering (PC-SERS) based detection. It is known that gold nanoparticles (AuNPs) display SERS...
-
[Illinois] Spectral Method for Linear and Nonlinear Phenomena in Nanophotonics
29 Dec 2014 | | Contributor(s):: Qing Huo Liu
-
[Illinois] Super-resolution imaging in plasmonics
17 Jun 2016 | | Contributor(s):: Katherine Willets
Super-resolution imaging in plasmonics Katherine Willets Department of Chemistry March 21, 2016 Plasmonics and its Applications Workshop Renewable and sustainable Energy Institute University of Colorado, Boulder Boulder, Co
-
[Illinois] Using Photonic Crystals to Enhance SERS Signals for Early Detection of Prostate Cancer
29 Jan 2016 | | Contributor(s):: Caitlin Race
Prostate cancer is the second most common cancer for men, and the second leading cause of death due to cancer in men. Currently, the most common screening method aims to detect high levels of prostate-specific antigen (PSA) in blood. Our research has shown the potential for both better prostate...